Seeking Alpha

Portola Pharmaceuticals beats by $0.02, misses on revenue

  • Portola Pharmaceuticals (NASDAQ:PTLA): Q2 EPS of -$0.76 beats by $0.02.
  • Revenue of $2.42M (-6.9% Y/Y) misses by $0.02M.
  • Press Release
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector